Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	histone H2AX kinase activity	ATR BAZ1B ATM	9.18e-06	5	196	3	GO:0141003
GeneOntologyBiologicalProcess	axoneme assembly	MNS1 DCX FSIP2 LRGUK DNAH5 DNAAF4 DNAH1 DNAAF1	8.30e-06	109	192	8	GO:0035082
GeneOntologyBiologicalProcess	microtubule bundle formation	MNS1 DCX FSIP2 LRGUK DNAH5 DNAAF4 DNAH1 KIF20A DNAAF1	8.88e-06	145	192	9	GO:0001578
Domain	TLE_N	TLE5 TLE1 TLE2	1.05e-05	5	192	3	PF03920
Domain	Groucho/TLE_N	TLE5 TLE1 TLE2	1.05e-05	5	192	3	IPR005617
Domain	CH	LRCH1 DST ASPM LRCH2 LRCH3 LRCH4	5.45e-05	65	192	6	SM00033
Domain	CH	LRCH1 DST ASPM LRCH2 LRCH3 LRCH4	8.29e-05	70	192	6	PF00307
Domain	-	LRCH1 DST ASPM LRCH2 LRCH3 LRCH4	8.98e-05	71	192	6	1.10.418.10
Domain	LRR_1	LRCH1 LRGUK FLII LRCH2 LRRK1 LRCH3 TLR1 LRCH4 LRRC8B DNAAF1	9.25e-05	219	192	10	PF00560
Domain	CH	LRCH1 DST ASPM LRCH2 LRCH3 LRCH4	1.05e-04	73	192	6	PS50021
Domain	DUF1866	SYNJ1 SYNJ2	1.05e-04	2	192	2	IPR015047
Domain	DUF1866	SYNJ1 SYNJ2	1.05e-04	2	192	2	PF08952
Domain	DUF1866	SYNJ1 SYNJ2	1.05e-04	2	192	2	SM01165
Domain	PHD	ASH1L MTF2 BAZ2B PHRF1 BAZ1B PHF14	1.22e-04	75	192	6	PF00628
Domain	CH-domain	LRCH1 DST ASPM LRCH2 LRCH3 LRCH4	1.22e-04	75	192	6	IPR001715
Domain	Znf_PHD-finger	ASH1L MTF2 BAZ2B PHRF1 BAZ1B PHF14	1.63e-04	79	192	6	IPR019787
Domain	ARM-type_fold	ATR INTS1 PSMD1 CLHC1 NF1 AP1G1 ASPM ZER1 NCAPD3 DOCK9 ATM STAG3	2.10e-04	339	192	12	IPR016024
Domain	LRR	LRCH1 LRGUK FLII LRCH2 LRRK1 TLR1 LRCH4 LRRC8B DNAAF1	2.40e-04	201	192	9	PS51450
Domain	PHD	ASH1L MTF2 BAZ2B PHRF1 BAZ1B PHF14	3.13e-04	89	192	6	SM00249
Domain	Znf_PHD	ASH1L MTF2 BAZ2B PHRF1 BAZ1B PHF14	3.53e-04	91	192	6	IPR001965
Domain	ZF_PHD_2	ASH1L MTF2 BAZ2B PHRF1 BAZ1B PHF14	4.44e-04	95	192	6	PS50016
Domain	ZF_PHD_1	ASH1L MTF2 BAZ2B PHRF1 BAZ1B PHF14	4.70e-04	96	192	6	PS01359
Domain	P-loop_NTPase	ERCC3 SETX MYO9A DHX38 PFKFB1 SMC5 LRGUK ASPM ABCG2 DNAH5 NWD1 EP400 LRRK1 DDX55 DIRAS3 DNAH1 KIF20A RERGL RASD1 SMC1B	4.77e-04	848	192	20	IPR027417
Domain	ARM-like	SETX ATR PSMD1 DAXX NF1 AP1G1 ASPM ZER1 NCAPD3 STAG3	4.98e-04	270	192	10	IPR011989
Domain	LRR_TYP	LRCH1 FLII LRCH2 LRRK1 LRCH3 TLR1 LRCH4 LRRC8B	5.00e-04	177	192	8	SM00369
Domain	Leu-rich_rpt_typical-subtyp	LRCH1 FLII LRCH2 LRRK1 LRCH3 TLR1 LRCH4 LRRC8B	5.00e-04	177	192	8	IPR003591
Domain	-	LRCH1 LRGUK ZER1 FLII LRCH2 LRRK1 LRCH3 TLR1 LRCH4 LRRC8B DNAAF1	5.06e-04	321	192	11	3.80.10.10
Domain	Leu-rich_rpt	LRCH1 LRGUK FLII LRCH2 LRRK1 LRCH3 TLR1 LRCH4 LRRC8B DNAAF1	5.13e-04	271	192	10	IPR001611
Domain	L_dom-like	LRCH1 LRGUK ZER1 FLII LRCH2 LRRK1 LRCH3 TLR1 LRCH4 LRRC8B DNAAF1	6.05e-04	328	192	11	IPR032675
Domain	Znf_FYVE_PHD	ASH1L MTF2 BAZ2B PHRF1 BAZ1B SYTL3 PHF14	8.25e-04	147	192	7	IPR011011
Domain	Prefoldin	TLE5 TXLNA TLE1 TLE2 ATP6V0A2	8.73e-04	72	192	5	IPR009053
Domain	DDT	BAZ2B BAZ1B	1.03e-03	5	192	2	SM00571
Domain	Groucho_enhance	TLE1 TLE2	1.03e-03	5	192	2	IPR009146
Domain	Syja_N	SYNJ1 SYNJ2	1.03e-03	5	192	2	PF02383
Domain	DDT_dom	BAZ2B BAZ1B	1.03e-03	5	192	2	IPR018501
Domain	WHIM2_dom	BAZ2B BAZ1B	1.03e-03	5	192	2	IPR028941
Domain	WSD	BAZ2B BAZ1B	1.03e-03	5	192	2	PF15613
Domain	FATC	ATR ATM	1.03e-03	5	192	2	PF02260
Domain	SAC	SYNJ1 SYNJ2	1.03e-03	5	192	2	PS50275
Domain	DUF4371	ZMYM1 THAP12	1.03e-03	5	192	2	IPR025398
Domain	DUF4371	ZMYM1 THAP12	1.03e-03	5	192	2	PF14291
Domain	SAC_dom	SYNJ1 SYNJ2	1.03e-03	5	192	2	IPR002013
Domain	-	UTP6 ATR TTC21A NRDE2 TTC28 DNAAF4 TEX11 TTC17	1.38e-03	207	192	8	1.25.40.10
Domain	DDT	BAZ2B BAZ1B	1.53e-03	6	192	2	PS50827
Domain	FAT	ATR ATM	1.53e-03	6	192	2	PS51189
Domain	FATC	ATR ATM	1.53e-03	6	192	2	PS51190
Domain	FAT	ATR ATM	1.53e-03	6	192	2	PF02259
Domain	PIK-rel_kinase_FAT	ATR ATM	1.53e-03	6	192	2	IPR003151
Domain	FATC_dom	ATR ATM	1.53e-03	6	192	2	IPR003152
Domain	PIK_FAT	ATR ATM	1.53e-03	6	192	2	IPR014009
Domain	FATC	ATR ATM	1.53e-03	6	192	2	SM01343
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	SETX RAPGEF5 UGGT1 DHX38 ASH1L PSMD1 DCX TRIM59 PTPRC SYNJ1 AP1G1 ANLN KCNH1 ALDH1L2 PGAP1 TASOR NRDE2 ANK3 DOCK9 BAZ1B ANKRD50 MTA1 IGF2R OSBPL3 ZMYM1 ATP6V0A2	7.95e-10	1084	199	26	11544199
Pubmed	LRCH proteins: a novel family of cytoskeletal regulators.	LRCH1 LRCH2 LRCH3 LRCH4	1.04e-09	4	199	4	20805893
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SETX ATR SENP3 DHX38 SRPK2 NSUN2 FAM111B DST AP1G1 TASOR NRDE2 NCAPD3 TTC28 ANKRD50 DDX55 ZXDB TXLNA OSBPL3 LRCH4 PRKCI	1.31e-09	650	199	20	38777146
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	ERCC3 SETX SENP3 DHX38 INTS1 SRPK2 DAXX DST AP1G1 ANLN SUMO1 HERC2 TASOR HNRNPLL NRDE2 NCAPD3 EP400 PHRF1 BAZ1B DDX55 LRCH3 MTA1 GZF1 LRCH4 PHF14 ZFHX3 THAP12 ATP6V0A2	3.76e-08	1497	199	28	31527615
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	UTP6 ERCC3 MIS18BP1 SETX AGO2 MYO9A CFL1 SENP3 DHX38 PSMD1 NSUN2 ACSL4 NF1 DST AP1G1 ANLN ASPM HERC2 FLII EP400 BAZ1B DGKD FASTKD2 KIF20A METTL13 SF3B3	7.16e-08	1353	199	26	29467282
Pubmed	DNA damage-induced ATM- and Rad-3-related (ATR) kinase activation in non-replicating cells is regulated by the XPB subunit of transcription factor IIH (TFIIH).	ERCC3 ATR ATM	1.85e-07	3	199	3	28592488
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	AGO2 CFL1 SENP3 SRPK2 DCX NF1 DST SYNJ1 HERC2 FLII BIN1 LRCH2 ANK3 RAPGEF4 GRIA2 TXLNA IGF2R OSBPL3 LRP1 PRKCI CTNNA1	1.86e-07	963	199	21	28671696
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SETX AGO2 LRCH1 DST SYNJ2 ADGRL2 NCAPD3 EP400 PHRF1 FASTKD2 LRRK1 ANKRD50 DDX55 SF3B3 NIN	4.63e-07	529	199	15	14621295
Pubmed	PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins.	TLE5 TLE1 TLE2	7.35e-07	4	199	3	9887105
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	SETX ATR SENP3 VPS33A INTS1 PSMD1 NF1 ANLN SUMO1 HNRNPLL EXOC5 METTL13 SF3B3 CTNNA1 ATM	1.52e-06	582	199	15	20467437
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	MIS18BP1 SETX MYO9A DHX38 DAXX FAM111B SYNJ1 ASPM EP400 TTC28 BAZ1B POLR3C SF3B3 ZNF92 NIN	1.72e-06	588	199	15	38580884
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	ERCC3 DHX38 SRPK2 DAXX NSUN2 NF1 HERC2 LRCH2 EP400 DDX55 LRCH3 KIF20A THAP12	1.76e-06	440	199	13	34244565
Pubmed	Molecular cloning and expression of mouse and human cDNA encoding AES and ESG proteins with strong similarity to Drosophila enhancer of split groucho protein.	TLE5 TLE1 TLE2	1.83e-06	5	199	3	8365415
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	AGO2 ASH1L SRPK2 SUCLG1 MALT1 ASPM ADGRL2 EP400 TTC28 PHRF1 BAZ1B KIF20A METTL13 MTA1 SF3B3 ZFHX4 OSBPL3 LRP1 ZFHX3 LRRC8B NIN	1.98e-06	1116	199	21	31753913
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	MIS18BP1 SETX INTS1 DAXX FSIP2 ANLN HERC2 MTF2 BAZ2B BAZ1B DDX55 KIF20A MTA1 PHF14 PRDM15	2.59e-06	608	199	15	36089195
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ATR PSMD1 DAXX NSUN2 NF1 PTPRC ANLN FLII NCAPD3 BIN1 EP400 PHRF1 BAZ1B MTA1 PHF14 CTNNA1 ATM	2.63e-06	774	199	17	15302935
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	SETX CCDC30 SENP3 DST ADGRL2 TASOR HNRNPLL FAT4 STON1 ANK3 EP400 TTC28 ANKRD50 KIF20A IGF2R ZFHX3 ATP6V0A2	2.77e-06	777	199	17	35844135
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	SETX SENP3 INTS1 TASOR EP400 TTC28 MTF2 PARP14 CCDC141 KIF20A MTA1 PHF14 CTNNA1	3.53e-06	469	199	13	27634302
Pubmed	Protein characterization and targeted disruption of Grg, a mouse gene related to the groucho transcript of the Drosophila Enhancer of split complex.	TLE5 TLE1 TLE2	3.64e-06	6	199	3	8573724
Pubmed	Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS.	MIS18BP1 ACOX1 SMC5 NSUN2 FLII BAZ2B BAZ1B PARP14 LRCH3 SF3B3 LRCH4	4.75e-06	340	199	11	29478914
Pubmed	The cell proliferation antigen Ki-67 organises heterochromatin.	UTP6 ERCC3 ATR SENP3 SRPK2 NF1 DST AP1G1 SUMO1 EP400 PARP14 METTL13	4.87e-06	410	199	12	26949251
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	AGO2 MYO9A TTC21A ASH1L PSMD1 SRPK2 ZNF385B PFKFB1 ZSWIM1 MALT1 TLE5 SYNJ2 NTN1 TRMT13 PLCB4 ANK3 LRCH3 DNAH1 LRP1 PHF14 ZFHX3 PRKCI TTC17 PRDM15	5.11e-06	1489	199	24	28611215
Pubmed	A Gro/TLE-NuRD corepressor complex facilitates Tbx20-dependent transcriptional repression.	TLE5 TLE1 TLE2	6.35e-06	7	199	3	24024827
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	UTP6 ATR CFL1 UGGT1 DHX38 PSMD1 NSUN2 NF1 AP1G1 SUMO1 DNAH5 HNRNPLL FLII NCAPD3 BAZ1B FASTKD2 DDX55 TXLNA METTL13 IGF2R SF3B3 PRKCI ATM	7.98e-06	1425	199	23	30948266
Pubmed	The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells.	ATR APOBEC3G ATM	1.01e-05	8	199	3	21874023
Pubmed	The Groucho-related gene family regulates the gonadotropin-releasing hormone gene through interaction with the homeodomain proteins MSX1 and OCT1.	TLE5 TLE1 TLE2	1.01e-05	8	199	3	16002402
Pubmed	Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif protein.	ATR APOBEC3G ATM	1.01e-05	8	199	3	23202519
Pubmed	Defining the membrane proteome of NK cells.	AGO2 CFL1 ACOX1 DHX38 INTS1 PSMD1 ACSL4 NF1 PTPRC AP1G1 HERC2 HNRNPLL NCAPD3 DOCK9 PHRF1 DDX55 PARP14 TXLNA IGF2R OSBPL3	1.40e-05	1168	199	20	19946888
Pubmed	BRCA1-mediated chromatin silencing is limited to oocytes with a small number of asynapsed chromosomes.	ATR STAG3 SMC1B	1.51e-05	9	199	3	19531582
Pubmed	Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2.	PSMD1 ASPM HERC2 FLII KIF20A CTNNA1 NIN	1.63e-05	139	199	7	25476789
Pubmed	Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins.	UTP6 CFL1 APOBEC3G SRPK2 SUCLG1 NSUN2 DST SUMO1 HNRNPLL FASTKD2 KIF20A SF3B3 PRKCI CTNNA1 NIN	2.02e-05	723	199	15	34133714
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	ERCC3 MIS18BP1 FAM111B DST ANLN CCDC14 FLII EP400 TTC28 DDX55 KIF20A TXLNA PRDM15 NIN	2.34e-05	645	199	14	25281560
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	ERCC3 MIS18BP1 ATR DHX38 INTS1 SMC5 NSUN2 ADK SUMO1 HNRNPLL EP400 BAZ1B POLR3C MTA1 SF3B3 TLE1 PHF14 ATM	2.40e-05	1014	199	18	32416067
Pubmed	A human MAP kinase interactome.	HDAC9 SETX MYO9A PSMD1 DAXX DST TLE5 SYNJ2 HERC2 CCDC14 ANK3 CTNNA1	2.64e-05	486	199	12	20936779
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	UTP6 UGGT1 DHX38 INTS1 PSMD1 NSUN2 NF1 DST HERC2 PHRF1 BAZ1B IGF2R CTNNA1 ATM	2.68e-05	653	199	14	22586326
Pubmed	Plk3 functionally links DNA damage to cell cycle arrest and apoptosis at least in part via the p53 pathway.	ATR PTPRC ATM	2.94e-05	11	199	3	11551930
Pubmed	Single-stranded DNA orchestrates an ATM-to-ATR switch at DNA breaks.	ATR ATM	3.26e-05	2	199	2	19285939
Pubmed	Expression variations of DNA damage response genes ATM and ATR in blood cancer patients.	ATR ATM	3.26e-05	2	199	2	37338595
Pubmed	Requirement of MTA1 in ATR-mediated DNA damage checkpoint function.	ATR MTA1	3.26e-05	2	199	2	20427275
Pubmed	DNA damage induces a kinetochore-based ATM/ATR-independent SAC arrest unique to the first meiotic division in mouse oocytes.	ATR ATM	3.26e-05	2	199	2	28851706
Pubmed	Novel insights into the mechanism of cell cycle kinases Mec1(ATR) and Tel1(ATM).	ATR ATM	3.26e-05	2	199	2	34151669
Pubmed	Netrin-1 and semaphorin 3A predict the development of acute kidney injury in liver transplant patients.	SEMA3A NTN1	3.26e-05	2	199	2	25289643
Pubmed	BCRP mRNA and FLT3-ITD are independent poor risk factors in adult patients with acute myeloid leukemia and intermediate or normal karyotype.	ABCG2 FLT3	3.26e-05	2	199	2	28618074
Pubmed	The Synaptojanins in the murine small and large intestine.	SYNJ1 SYNJ2	3.26e-05	2	199	2	27878645
Pubmed	Inhibition of Atm and/or Atr disrupts gene silencing on the inactive X chromosome.	ATR ATM	3.26e-05	2	199	2	16213462
Pubmed	ATR- and ATM-Mediated DNA Damage Response Is Dependent on Excision Repair Assembly during G1 but Not in S Phase of Cell Cycle.	ATR ATM	3.26e-05	2	199	2	27442013
Pubmed	Induction of ATM/ATR pathway combined with Vγ2Vδ2 T cells enhances cytotoxicity of ovarian cancer cells.	ATR ATM	3.26e-05	2	199	2	24726882
Pubmed	rRNA synthesis inhibitor, CX-5461, activates ATM/ATR pathway in acute lymphoblastic leukemia, arrests cells in G2 phase and induces apoptosis.	ATR ATM	3.26e-05	2	199	2	26061708
Pubmed	Long noncoding RNA DIAPH2-AS1 promotes neural invasion of gastric cancer via stabilizing NSUN2 to enhance the m5C modification of NTN1.	NSUN2 NTN1	3.26e-05	2	199	2	37037818
Pubmed	Semaphorin-3A and Netrin-1 predict the development of kidney injury in children with congenital hydronephrosis.	SEMA3A NTN1	3.26e-05	2	199	2	29199452
Pubmed	Functional significance for a heterogenous ribonucleoprotein A18 signature RNA motif in the 3'-untranslated region of ataxia telangiectasia mutated and Rad3-related (ATR) transcript.	ATR ATM	3.26e-05	2	199	2	20103595
Pubmed	Hantavirus nucleocapsid protein interacts with the Fas-mediated apoptosis enhancer Daxx.	DAXX SUMO1	3.26e-05	2	199	2	11907324
Pubmed	Interplay between ATM and ATR in the regulation of common fragile site stability.	ATR ATM	3.26e-05	2	199	2	17934520
Pubmed	Depletion of ATR selectively sensitizes ATM-deficient human mammary epithelial cells to ionizing radiation and DNA-damaging agents.	ATR ATM	3.26e-05	2	199	2	25483091
Pubmed	ATM and ATR activities maintain replication fork integrity during SV40 chromatin replication.	ATR ATM	3.26e-05	2	199	2	23592994
Pubmed	Loss of hnRNPLL-dependent splicing of Ptprc has no impact on B-cell development, activation and terminal differentiation into antibody-secreting cells.	PTPRC HNRNPLL	3.26e-05	2	199	2	33331104
Pubmed	The mouse ZFH-4 protein contains four homeodomains and twenty-two zinc fingers.	ZFHX4 ZFHX3	3.26e-05	2	199	2	10873665
Pubmed	Bleomycin-induced over-replication involves sustained inhibition of mitotic entry through the ATM/ATR pathway.	ATR ATM	3.26e-05	2	199	2	19527713
Pubmed	Grg1 acts as a lung-specific oncogene in a transgenic mouse model.	TLE5 TLE1	3.26e-05	2	199	2	16452182
Pubmed	ATM and ATR signaling at a glance.	ATR ATM	3.26e-05	2	199	2	26567218
Pubmed	NMR chemical shift assignments of a complex between SUMO-1 and SIM peptide derived from the C-terminus of Daxx.	DAXX SUMO1	3.26e-05	2	199	2	20927612
Pubmed	Cancer genome datamining and functional genetic analysis implicate mechanisms of ATM/ATR dysfunction underpinning carcinogenesis.	ATR ATM	3.26e-05	2	199	2	33742106
Pubmed	Structural Insight into Binding of the ZZ Domain of HERC2 to Histone H3 and SUMO1.	SUMO1 HERC2	3.26e-05	2	199	2	32726574
Pubmed	Roles of ATM and ATR in DNA double strand breaks and replication stress.	ATR ATM	3.26e-05	2	199	2	33887296
Pubmed	ATR disruption leads to chromosomal fragmentation and early embryonic lethality.	ATR ATM	3.26e-05	2	199	2	10691732
Pubmed	A cell-based screen for splicing regulators identifies hnRNP LL as a distinct signal-induced repressor of CD45 variable exon 4.	PTPRC HNRNPLL	3.26e-05	2	199	2	18719244
Pubmed	Hypoosmotic stress induces R loop formation in nucleoli and ATR/ATM-dependent silencing of nucleolar transcription.	ATR ATM	3.26e-05	2	199	2	31114877
Pubmed	Shift in G1-Checkpoint from ATM-Alone to a Cooperative ATM Plus ATR Regulation with Increasing Dose of Radiation.	ATR ATM	3.26e-05	2	199	2	35011623
Pubmed	The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo.	ATR ATM	3.26e-05	2	199	2	26517239
Pubmed	NF1 patient missense variants predict a role for ATM in modifying neurofibroma initiation.	NF1 ATM	3.26e-05	2	199	2	31664505
Pubmed	DNA damage-sensing kinases mediate the mouse 2-cell embryo's response to genotoxic stress.	ATR ATM	3.26e-05	2	199	2	21593482
Pubmed	A synthetic lethal screen reveals enhanced sensitivity to ATR inhibitor treatment in mantle cell lymphoma with ATM loss-of-function.	ATR ATM	3.26e-05	2	199	2	25232030
Pubmed	Lack of CD45 in FLT3-ITD mice results in a myeloproliferative phenotype, cortical porosity, and ectopic bone formation.	PTPRC FLT3	3.26e-05	2	199	2	30820040
Pubmed	ATM acts downstream of ATR in the DNA damage response signaling of bystander cells.	ATR ATM	3.26e-05	2	199	2	18757420
Pubmed	Cellular responses to the DNA strand-scission enediyne C-1027 can be independent of ATM, ATR, and DNA-PK kinases.	ATR ATM	3.26e-05	2	199	2	11927575
Pubmed	In Vivo and In Vitro Effects of ATM/ATR Signaling Pathway on Proliferation, Apoptosis, and Radiosensitivity of Nasopharyngeal Carcinoma Cells.	ATR ATM	3.26e-05	2	199	2	28820634
Pubmed	ATM and ATR play complementary roles in the behavior of excitatory and inhibitory vesicle populations.	ATR ATM	3.26e-05	2	199	2	29279380
Pubmed	ATR regulates fragile site stability.	ATR ATM	3.26e-05	2	199	2	12526805
Pubmed	NMR characterization of conformational fluctuations and noncovalent interactions of SUMO protein from Drosophila melanogaster (dSmt3).	DAXX SUMO1	3.26e-05	2	199	2	30958586
Pubmed	Transcription factor ZFHX3 regulates calcium influx in mammary epithelial cells in part via the TRPV6 calcium channel.	TRPV6 ZFHX3	3.26e-05	2	199	2	31519324
Pubmed	Investigation of switch from ATM to ATR signaling at the sites of DNA damage induced by low and high LET radiation.	ATR ATM	3.26e-05	2	199	2	24238855
Pubmed	Mutagenesis as an unbiased approach to identify novel contraceptive targets.	DNAH1 SMC1B	3.26e-05	2	199	2	16412559
Pubmed	Recruitment of ATR to sites of ionising radiation-induced DNA damage requires ATM and components of the MRN protein complex.	ATR ATM	3.26e-05	2	199	2	16474843
Pubmed	The Atr and Atm protein kinases associate with different sites along meiotically pairing chromosomes.	ATR ATM	3.26e-05	2	199	2	8843195
Pubmed	Viral DNA replication-dependent DNA damage response activation during BK polyomavirus infection.	ATR ATM	3.26e-05	2	199	2	25694603
Pubmed	Ataxia-Telangiectasia and RAD3-Related and Ataxia-Telangiectasia-Mutated Proteins in Epithelial Ovarian Carcinoma: Their Expression and Clinical Significance.	ATR ATM	3.26e-05	2	199	2	26124337
Pubmed	Resveratrol analogue (E)-8-acetoxy-2-[2-(3,4-diacetoxyphenyl)ethenyl]-quinazoline induces G₂/M cell cycle arrest through the activation of ATM/ATR in human cervical carcinoma HeLa cells.	ATR ATM	3.26e-05	2	199	2	25812484
Pubmed	Roles of ATM and ATR-mediated DNA damage responses during lytic BK polyomavirus infection.	ATR ATM	3.26e-05	2	199	2	22952448
Pubmed	ATM regulates ATR chromatin loading in response to DNA double-strand breaks.	ATR ATM	3.26e-05	2	199	2	16461339
Pubmed	ATR localizes to the photoreceptor connecting cilium and deficiency leads to severe photoreceptor degeneration in mice.	ATR ATM	3.26e-05	2	199	2	23297361
Pubmed	Developmentally regulated alternative splicing in a novel synaptojanin.	SYNJ1 SYNJ2	3.26e-05	2	199	2	9442075
Pubmed	Inactivation of ATM/ATR DNA damage checkpoint promotes androgen induced chromosomal instability in prostate epithelial cells.	ATR ATM	3.26e-05	2	199	2	23272087
Pubmed	The Dimeric Architecture of Checkpoint Kinases Mec1ATR and Tel1ATM Reveal a Common Structural Organization.	ATR ATM	3.26e-05	2	199	2	27129217
Pubmed	Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse.	ABCG2 FLT3	3.26e-05	2	199	2	21523728
Pubmed	Dynamic dependence on ATR and ATM for double-strand break repair in human embryonic stem cells and neural descendants.	ATR ATM	3.26e-05	2	199	2	20368801
Pubmed	Clinicopathological significance of ataxia telangiectasia-mutated (ATM) kinase and ataxia telangiectasia-mutated and Rad3-related (ATR) kinase in MYC overexpressed breast cancers.	ATR ATM	3.26e-05	2	199	2	30746633
Pubmed	Proficiency in homologous recombination repair is prerequisite for activation of G2-checkpoint at low radiation doses.	ATR ATM	3.26e-05	2	199	2	33640756
Pubmed	A role for ATR in the DNA damage-induced phosphorylation of p53.	ATR ATM	3.26e-05	2	199	2	9925639
Pubmed	Analysis of mutations that dissociate G(2) and essential S phase functions of human ataxia telangiectasia-mutated and Rad3-related (ATR) protein kinase.	ATR ATM	3.26e-05	2	199	2	21908846
Pubmed	The ATM and Rad3-Related (ATR) Protein Kinase Pathway Is Activated by Herpes Simplex Virus 1 and Required for Efficient Viral Replication.	ATR ATM	3.26e-05	2	199	2	29263259
Interaction	DDX46 interactions	AGO2 PSMD1 SRPK2 SMC5 ANLN SUMO1 USP4 HERC2 TASOR ANKRD50 KIF20A SF3B3	2.16e-06	227	194	12	int:DDX46
Interaction	H2BC9 interactions	ASH1L ZNF385B SMC5 TEX35 FSIP2 ACSL4 DST SYNJ2 DNAH5 LRCH2 BAZ2B BAZ1B DGKD PREX2 DNAH1 ZFHX4	7.04e-06	446	194	16	int:H2BC9
Interaction	LRCH3 interactions	LRCH1 ANLN LRCH2 ANK3 ANKRD50 LRCH3 KIF20A LRCH4	9.88e-06	108	194	8	int:LRCH3
Interaction	NEUROG3 interactions	SETX MYO9A CFL1 SPEG NSUN2 DST ASPM ZER1 NTN1	1.44e-05	149	194	9	int:NEUROG3
Interaction	MKI67 interactions	UTP6 HDAC9 ERCC3 ATR SENP3 SRPK2 DAXX SMC5 NF1 DST AP1G1 ANLN SUMO1 ASPM EP400 PARP14 KIF20A HINFP METTL13	1.71e-05	648	194	19	int:MKI67
Interaction	MAGEA9 interactions	MYO9A ASH1L SYNJ1 ASPM TRMT13 HERC2 CCDC14 NCAPD3 ZFHX4 UBR3	3.50e-05	208	194	10	int:MAGEA9
Interaction	RIPPLY2 interactions	TLE5 USP4 TLE1 TLE2	3.57e-05	20	194	4	int:RIPPLY2
Interaction	LZTS2 interactions	ERCC3 MIS18BP1 AGO2 MYO9A VPS33A TLE5 ANLN ASPM FLII NCAPD3 ANK3 TTC28 DIRAS3 MTA1 CTNNA1 ZMYM1	3.82e-05	512	194	16	int:LZTS2
Cytoband	Xq22.3-q23	DCX ACSL4	5.59e-05	3	199	2	Xq22.3-q23
GeneFamily	PHD finger proteins	ASH1L MTF2 BAZ2B PHRF1 BAZ1B PHF14	5.09e-05	90	132	6	88
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	SETX AGO2 ATR SRPK2 SMC5 ACSL4 MALT1 DST SYNJ2 ANKMY2 PLCB4 TASOR TTC28 MTF2 BAZ2B DOCK9 BAZ1B IGF2R TLE1 PHF14 ZFHX3 PRKCI	5.60e-07	856	197	22	M4500
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	AGO2 MALT1 DST SYNJ2 DOCK9 PHF14 ZFHX3	3.38e-06	84	197	7	M13008
Coexpression	LAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED	SRPK2 SEMA3A PLCB4 DOCK9 ZFHX3	9.35e-06	38	197	5	M39244
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	SETX AGO2 SENP3 INTS1 APOBEC3G SRPK2 ADK ACSL4 MALT1 SUMO1 ANKMY2 USP4 TASOR FLT3 BIN1 MTF2 FASTKD2 LRCH3 POLR3C EXOC5 PRKCI MRPL3 CTNNA1 ATM	1.56e-05	1215	197	24	M41122
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_500	ATR MYO9A TEX11 TEX30 ATM STAG3 SMC1B	2.98e-06	69	192	7	gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_500
CoexpressionAtlas	dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_500	ATR TEX11 TEX30 ATM STAG3 SMC1B	1.13e-05	56	192	6	gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_500
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_500	MIS18BP1 SETX MNS1 ATR MYO9A ZSWIM1 PGAP1 DNAAF4 TEX11 TEX30 ZMYM1 ATM STAG3 SMC1B	1.59e-05	396	192	14	gudmap_dev gonad_e13.5_M_GermCell_Oct_500
CoexpressionAtlas	B cells, B.Fo.PC, IgD+ IgM+ CD19+ CD43- CD5- CD23+, Peritoneal Cavity, avg-3	HDAC9 TRIM59 CXCR5 MALT1 PGAP1 GPR171 KLHL14 MAP3K19 FLT3 BAZ2B RAPGEF4 DGKD TLR1	2.04e-05	352	192	13	GSM538198_500
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000	MIS18BP1 SETX MNS1 ATR MYO9A SENP3 ZSWIM1 BNC1 ANLN PGAP1 NCAPD3 MTF2 DNAAF4 TEX11 TEX30 SF3B3 ZMYM1 ATM STAG3 SMC1B	4.80e-05	810	192	20	gudmap_dev gonad_e13.5_M_GermCell_Oct_1000
CoexpressionAtlas	dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#4_top-relative-expression-ranked_1000	ATR PFKFB1 TEX11 TEX30 STAG3 SMC1B	4.81e-05	72	192	6	gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k4_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3	MIS18BP1 MNS1 ASH1L SRPK2 SMC5 PLXNA2 USP50 TTC28 BAZ1B PHF14 NIN	7.24e-05	291	192	11	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3
CoexpressionAtlas	B cells, B.Fo.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1- CD23+, Spleen, avg-3	HDAC9 RAPGEF5 NOXRED1 TRIM59 CXCR5 MALT1 PGAP1 KLHL14 MAP3K19 RAPGEF4 DGKD TLR1	7.57e-05	345	192	12	GSM538201_500
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000	HDAC9 MIS18BP1 ATR MYO9A ASH1L ZNF385B PFKFB1 BNC1 SYNJ1 CAPS2 GARNL3 MTF2 DGKD TEX11 EXOC5 TEX30 ATM STAG3 SMC1B	8.35e-05	776	192	19	gudmap_developingGonad_e14.5_ ovary_1000
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_1000	ATR PFKFB1 TEX11 TEX30 ATM STAG3 SMC1B	8.52e-05	115	192	7	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_1000
CoexpressionAtlas	B cells, B.T3.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1+ CD23+, Spleen, avg-3	HDAC9 RAPGEF5 NOXRED1 TRIM59 CXCR5 MALT1 PGAP1 KLHL14 MAP3K19 RAPGEF4 DGKD TLR1	1.16e-04	361	192	12	GSM538219_500
CoexpressionAtlas	B cells, B.FrF.BM, CD19+ IgM+ AA4.1- HSA+, Bone marrow, avg-3	HDAC9 RAPGEF5 NOXRED1 CXCR5 MALT1 PGAP1 KLHL14 MAP3K19 BAZ2B RAPGEF4 DGKD TLR1	1.35e-04	367	192	12	GSM399440_500
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000	MIS18BP1 SETX MNS1 ATR SENP3 PFKFB1 ZSWIM1 ANLN PGAP1 GPR171 CCDC14 NCAPD3 TEX11 TEX30 SF3B3 ZMYM1 ATM STAG3 SMC1B	1.76e-04	822	192	19	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	EPHB4 SETX RAPGEF5 ASH1L DST PLCB4 ADGRL2 FAT4 BAZ2B DOCK9 RAPGEF4 PREX2 NIN	7.16e-12	200	199	13	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	EPHB4 SETX RAPGEF5 DST PLCB4 ADGRL2 FAT4 BAZ2B DOCK9 RAPGEF4 PREX2	1.80e-09	200	199	11	b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MNS1 CCDC30 TTC21A CLHC1 ARMH2 DNAH5 MAP3K19 DNAAF4 DNAH1 DNAAF1	9.08e-09	180	199	10	92fb01b91261b3103454924cde56add337b41844
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RAPGEF5 SRPK2 DST PLCB4 ADGRL2 FAT4 BAZ2B DOCK9 RAPGEF4 PREX2	1.85e-08	194	199	10	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	Control_saline-Epithelial_airway-airway_epithelial-Ciliated\|Control_saline / Treatment groups by lineage, cell group, cell type	MNS1 TTC21A CAPS2 DNAH5 BBOX1 MAP3K19 NWD1 DNAAF4 DNAH1 DNAAF1	1.95e-08	195	199	10	60067b5359174f0d1a8b5748bfc0690762e9e740
ToppCell	LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	TTC21A LRGUK CAPS2 DNAH5 ERICH6 MAP3K19 NWD1 DNAAF4 AGR3 DNAH1	2.36e-08	199	199	10	15f7814b7074170eee7ccacaa670b1d128fc68bb
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	EPHB4 SETX RAPGEF5 DST PLCB4 ADGRL2 DOCK9 RAPGEF4 PARP14 CTNNA1	2.48e-08	200	199	10	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	EPHB4 SETX RAPGEF5 DST PLCB4 FAT4 BAZ2B DOCK9 RAPGEF4 PREX2	2.48e-08	200	199	10	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	EPHB4 RAPGEF5 DST PLCB4 ADGRL2 DOCK9 RAPGEF4 PARP14 PREX2 CTNNA1	2.48e-08	200	199	10	4bb609a284d4e6066f17470a1736076aa4a1f84c
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	EPHB4 SETX RAPGEF5 DST PLCB4 ADGRL2 DOCK9 RAPGEF4 PARP14 CTNNA1	2.48e-08	200	199	10	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	LPS_only-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	EPHB4 RAPGEF5 DST PLCB4 ADGRL2 DOCK9 RAPGEF4 PARP14 PREX2 CTNNA1	2.48e-08	200	199	10	81e76508c9050d533853d5fd2f3097b27613d836
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	EPHB4 SETX RAPGEF5 DST PLCB4 FAT4 BAZ2B DOCK9 RAPGEF4 PREX2	2.48e-08	200	199	10	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	droplet-Lung-LUNG-30m-Endothelial-Vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB4 RAPGEF5 ADK DST KCNH1 NTN1 PLCB4 ABCG2 ADGRL2	1.66e-07	186	199	9	41f1674afc17661eccaa779cdeb663db5e45685d
ToppCell	droplet-Lung-LUNG-30m-Endothelial-vein_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPHB4 RAPGEF5 ADK DST KCNH1 NTN1 PLCB4 ABCG2 ADGRL2	1.66e-07	186	199	9	aa006650cf21a2c51dfe1091681f67fdad939107
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	SRPK2 JMY MALT1 PGAP1 GPR171 BIN1 ANK3 LRRK1 NIN	1.99e-07	190	199	9	91ba66d4b56c59523485b17738e93f14bb00afa4
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MNS1 CCDC30 TTC21A DNAH5 MAP3K19 NWD1 DNAAF4 AGR3 DNAAF1	2.48e-07	195	199	9	649fd2336e963f6a150d182a53ad5dd838ca80b1
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MNS1 CCDC30 TTC21A DNAH5 MAP3K19 NWD1 DNAAF4 AGR3 DNAAF1	2.48e-07	195	199	9	129ad5f4253ecb1a8477cc38773e6e91ea9570b0
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MNS1 CCDC30 TTC21A DNAH5 MAP3K19 NWD1 DNAAF4 AGR3 DNAAF1	2.48e-07	195	199	9	3e70ee987d66d450062d5df3d7c733ccc7344470
ToppCell	moderate-Epithelial-Ciliated\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MNS1 CCDC30 TTC21A DNAH5 MAP3K19 NWD1 DNAAF4 AGR3 DNAAF1	2.48e-07	195	199	9	e80f5cdf0b18066b3e6c2f5452e58f101c67932c
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TTC21A ANLN DNAH5 MAP3K19 NRAP MYO1H DNAH1 KIF20A DNAAF1	2.70e-07	197	199	9	6e4a411ef823ce9e16f420e185e21fa19d13af34
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MNS1 CCDC30 TTC21A LRGUK CAPS2 DNAH5 DNAAF4 OSBPL3 DNAAF1	2.70e-07	197	199	9	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	mild-B_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	HDAC9 RAPGEF5 CXCR5 ADK KLHL14 DGKD PARP14 TLE1 STAG3	3.07e-07	200	199	9	222789b897e2a683bbfd1d00b6fd8705015d90df
ToppCell	COVID-19_Severe-B_cell\|World / disease group, cell group and cell class	PDE6A GALR1 CXCR5 USP50 GARNL3 TLE1 STAG3 PRODH	3.72e-07	149	199	8	9a9fcbf7e8a6811958f3fd2d36315e19ab2b1127
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CCDC30 TTC21A LRGUK PGAP1 MAP3K19 USP50 DNAH1 DNAAF1	9.66e-07	169	199	8	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	facs-Heart-RA-3m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF112 TRIM59 CXCR5 MALT1 PTPRC PGAP1 GPR171 KLHL14	1.15e-06	173	199	8	1cfbab6603f8baf8e238837bb72740c43a7dc0ec
ToppCell	facs-Heart-RA-3m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF112 TRIM59 CXCR5 MALT1 PTPRC PGAP1 GPR171 KLHL14	1.15e-06	173	199	8	49030c2dd04b592655df1a667e2f90efb499e0a5
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-ILCP\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HDAC9 MIS18BP1 TEX35 JMY CXCR5 CCDC141 TEX30 RASD1	1.31e-06	176	199	8	238244294d08975df6bfa26b2b437db3654408ae
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MNS1 LRGUK FER1L5 DNAH5 MAP3K19 NWD1 AGR3 DNAAF1	1.31e-06	176	199	8	dee780cfa85234a7cd7bf440b66b84cec959893e
ToppCell	BAL-Severe-Lymphocyte-B-B_cell\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HDAC9 TRIM59 CXCR5 TASOR LRRK1 DDX55 CCDC141 STAG3	1.55e-06	180	199	8	c3c72531af5b9f7a7416727fe609dab5180e03b6
ToppCell	BAL-Severe-Lymphocyte-B-B_cell-B_cell-B_activate-7\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HDAC9 TRIM59 CXCR5 TASOR LRRK1 DDX55 CCDC141 STAG3	1.55e-06	180	199	8	9f4bbaf6435c23e3e552ae22be8ea7884314192d
ToppCell	BAL-Severe-Lymphocyte-B-B_cell-B_cell\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HDAC9 TRIM59 CXCR5 TASOR LRRK1 DDX55 CCDC141 STAG3	1.55e-06	180	199	8	b465f2f8b0e9a2034a4f1272bb00c77439164dbf
ToppCell	facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MNS1 CCDC30 LRGUK DNAH5 MAP3K19 AGR3 DNAH1 DNAAF1	2.06e-06	187	199	8	04dba2ed09ee4180830bdf0191921696697ea234
ToppCell	COVID-19-Heart-EC_2\|Heart / Disease (COVID-19 only), tissue and cell type	RAPGEF5 SYNJ2 PLCB4 PLXNA2 FAT4 DOCK9 PARP14 PREX2	2.06e-06	187	199	8	40ffc06a3e3251d9b12da390210d3e045af7537a
ToppCell	facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MNS1 CCDC30 LRGUK DNAH5 MAP3K19 AGR3 DNAH1 DNAAF1	2.06e-06	187	199	8	805dafe22f835ece4dd091d8030d0a63b52a48dd
ToppCell	COVID-19-lung-Artery_EC\|lung / Disease (COVID-19 only), tissue and cell type	RAPGEF5 SYNJ2 PLCB4 FAT4 TTC28 DOCK9 RAPGEF4 PREX2	2.15e-06	188	199	8	eecd7482b3c97d7f49993cb17edfab30c61232fc
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RAPGEF5 SYNJ2 PLCB4 PLXNA2 TTC28 DOCK9 RAPGEF4 PREX2	2.23e-06	189	199	8	6463890d8dbee4bc198f91628a5f784970de786a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RAPGEF5 FAM111B ANLN ASPM NCAPD3 DOCK9 RAPGEF4 KIF20A	2.32e-06	190	199	8	31de1727822e9818652946dfb962daee77ffad68
ToppCell	COVID-19-Endothelial_cells-Endothelial_cells_(general)\|COVID-19 / group, cell type (main and fine annotations)	RAPGEF5 PLCB4 ADGRL2 PLXNA2 TTC28 DOCK9 RAPGEF4 PREX2	2.32e-06	190	199	8	812e11314c76c0179fbe5a9bea29b41ce5cbc93d
ToppCell	COVID-19-lung-Vein_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HDAC9 RAPGEF5 PLCB4 ADGRL2 FAT4 DOCK9 RAPGEF4 PREX2	2.32e-06	190	199	8	1caeaef78326734c1e31a0c4739190d5c5a77b9e
ToppCell	COVID-19-Endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	RAPGEF5 PLCB4 ADGRL2 PLXNA2 TTC28 DOCK9 RAPGEF4 PREX2	2.32e-06	190	199	8	9fbd92cd6d4683b2490504d29c43cf42020433d4
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CCDC30 TTC21A DNAH5 PLXNA2 MAP3K19 NWD1 ANK3 DNAAF1	2.61e-06	193	199	8	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RAPGEF5 SRPK2 PLCB4 ADGRL2 FAT4 DOCK9 RAPGEF4 PREX2	2.61e-06	193	199	8	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	LRCH1 FAM111B FSIP2 SYNJ2 ASPM NRDE2 METTL13 OSBPL3	2.71e-06	194	199	8	8f4b63b0b9a40765205e4ca6bd94a675a83dbe3d
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MNS1 CCDC30 TTC21A LRGUK DNAH5 MAP3K19 DNAAF4 DNAAF1	2.71e-06	194	199	8	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	moderate-Epithelial-FOXN4+\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MIS18BP1 AGO2 SMC5 FAM111B ANLN ASPM CCDC14 TEX30	2.71e-06	194	199	8	dff3fb10372053951d41e0ccd41aac3ece6009bd
ToppCell	mild_COVID-19_(asymptomatic)-B_naive\|World / disease group, cell group and cell class (v2)	RAPGEF5 FAM111B CXCR5 ADK KLHL14 PARP14 TLE1 ZNF92	2.82e-06	195	199	8	e763d9a431052c03cc6d514f2736506c6667e2be
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38\|World / Primary Cells by Cluster	PGAP1 PLCB4 PLXNA2 TTC28 BAZ2B ZFHX4 RASD1 PHF14	2.92e-06	196	199	8	38da0751941adca650fe9b383d9f343153978eb5
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn\|World / Primary Cells by Cluster	PGAP1 PLCB4 PLXNA2 TTC28 BAZ2B ZFHX4 RASD1 PHF14	2.92e-06	196	199	8	721650a08d260faf530dbd52d4e9275d27f3bac2
ToppCell	NS-control-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MNS1 CCDC30 TTC21A DNAH5 MAP3K19 DNAAF4 AGR3 DNAAF1	2.92e-06	196	199	8	d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a
ToppCell	NS-moderate-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MNS1 CCDC30 TTC21A DNAH5 MAP3K19 NWD1 DNAAF4 DNAAF1	3.04e-06	197	199	8	71fea4aa6ce96c7693fa94792d08770622873850
ToppCell	COVID-19-lung-Capillary_1\|lung / Disease (COVID-19 only), tissue and cell type	RAPGEF5 LRCH1 ADGRL2 FAT4 TTC28 DOCK9 RAPGEF4 PREX2	3.04e-06	197	199	8	7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4
ToppCell	nucseq-Endothelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RAPGEF5 SEMA3A PLCB4 ADGRL2 TTC28 DOCK9 RAPGEF4 PREX2	3.04e-06	197	199	8	ebf9be068eaa658493fa7884fd19f34642922acb
ToppCell	control-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MNS1 CCDC30 TTC21A DNAH5 MAP3K19 DNAAF4 AGR3 DNAAF1	3.04e-06	197	199	8	e453d085182364ca347cbcc9dc995c62c3353016
ToppCell	control-Epithelial-Ciliated\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MNS1 CCDC30 TTC21A DNAH5 MAP3K19 DNAAF4 AGR3 DNAAF1	3.04e-06	197	199	8	d4e963c1f82996371bf3d63578ee9fce8e00c5a8
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MNS1 CCDC30 TTC21A ARMH2 DNAH5 DNAAF4 AGR3 DNAAF1	3.40e-06	200	199	8	cc906ff02fd335ff633b3b97afceb670494f910a
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SETX RAPGEF5 DST ADGRL2 DOCK9 ANKRD50 PARP14 CTNNA1	3.40e-06	200	199	8	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	LPS_anti-TNF-Endothelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	EPHB4 SETX RAPGEF5 DST PLCB4 ADGRL2 DOCK9 RAPGEF4	3.40e-06	200	199	8	1d105eeda5a2c51f9a4654ffc79b7e2348ad593b
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MNS1 CCDC30 TTC21A ARMH2 DNAH5 DNAAF4 AGR3 DNAAF1	3.40e-06	200	199	8	873def69bf55ccbfc944bc10c5afc06be019c312
ToppCell	LPS_IL1RA_TNF-Endothelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	EPHB4 SETX RAPGEF5 PLCB4 ADGRL2 DOCK9 RAPGEF4 PARP14	3.40e-06	200	199	8	d01cec331be3b03cef80e9536fc531285bcf00f6
ToppCell	LPS_anti-TNF-Endothelial-Endothelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	EPHB4 SETX RAPGEF5 DST PLCB4 ADGRL2 DOCK9 RAPGEF4	3.40e-06	200	199	8	60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Vein\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	EPHB4 HDAC9 DST PGAP1 PLCB4 RAPGEF4 PREX2 TLE1	3.40e-06	200	199	8	7eb366b2c5394af7c77650bde6261e7dac67154e
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MNS1 CCDC30 TTC21A ARMH2 DNAH5 DNAAF4 AGR3 DNAAF1	3.40e-06	200	199	8	79e59ab31d3d3385b1b072dc75508af9546c2e1b
ToppCell	LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MNS1 DNAH5 BBOX1 MAP3K19 NWD1 DNAAF4 DNAH1 DNAAF1	3.40e-06	200	199	8	4992dbf0514d674017315dbd20d91dfec0c608e9
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	EPHB4 SETX RAPGEF5 PLCB4 ADGRL2 DOCK9 RAPGEF4 PARP14	3.40e-06	200	199	8	a1fa6bae5a688faf488d6925cd3fad725dfa916b
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Interneuron\|5w / Sample Type, Dataset, Time_group, and Cell type.	CFL1 DCX SEMA3A ANK3 GRIA2 DIRAS3 RASD1 ZFHX3	3.40e-06	200	199	8	c7e33057466915d4e2b34f2062b22d9cdffa69dc
ToppCell	LPS-IL1RA-Epithelial_airway-Ciliated_cells\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LRGUK DNAH5 BBOX1 MAP3K19 NWD1 DNAH1 DNAAF1	5.37e-06	151	199	7	81cf939ed4df9574fbfff265e109cb9f947d7e6e
ToppCell	LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LRGUK DNAH5 BBOX1 MAP3K19 NWD1 DNAH1 DNAAF1	5.37e-06	151	199	7	9cbcbbc22965a9f0be8364e733d205dd64f2a533
ToppCell	390C-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FAM111B BMP5 DST ABCG2 DIRAS3 DNAH1 TLR1	5.61e-06	152	199	7	4a749d1b6d35fd55a8c42d7bd04b6ff5b11ce781
ToppCell	390C-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FAM111B BMP5 DST ABCG2 DIRAS3 DNAH1 TLR1	5.61e-06	152	199	7	ebce79e106bf1d84241f8dd3496ff1771f9666be
ToppCell	COVID-19_Severe-B_cell\|COVID-19_Severe / disease group, cell group and cell class	PDE6A GALR1 CXCR5 USP50 GARNL3 TLE1 PRODH	5.85e-06	153	199	7	701a7d92ee7b22277c8462742a530347cc6f061a
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LRGUK CAPS2 DNAH5 MAP3K19 NWD1 DNAH1 DNAAF1	6.37e-06	155	199	7	5f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LRGUK CAPS2 DNAH5 MAP3K19 NWD1 DNAH1 DNAAF1	6.37e-06	155	199	7	0944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Adult / Lineage, Cell type, age group and donor	ZNF385B ADK DNAH5 ANK3 AGR3 RASD1 PRKCI	8.86e-06	163	199	7	e819a1d6d28290854aa0672b3a18fa9e293d8f23
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	HDAC9 LRCH1 ADK DNAAF4 DGKD PARP14 TLE1	8.86e-06	163	199	7	6bed27d2f67a430a847da5eb47878d14b4949c45
ToppCell	PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MIS18BP1 CLHC1 CXCR5 ANLN ASPM KLHL14 NCAPD3	9.22e-06	164	199	7	249d8f75a64bce7db52ce0c563f496b9edf602a6
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	EPHB4 HDAC9 PLCB4 FAT4 RAPGEF4 PREX2 DIRAS3	1.04e-05	167	199	7	d7fe24cdc4b55a9555ce9e20699f5036b88148e9
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 FAM111B PTPRC ANLN ASPM CCDC141 KIF20A	1.12e-05	169	199	7	54b13ab02b4c187f4754045ecfcf409749e7ccc0
ToppCell	facs-Lung-nan-3m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CXCR5 MALT1 PTPRC PGAP1 GPR171 KLHL14 TLR1	1.21e-05	171	199	7	a31c23406cf6d6a17358a8fb41d392a7fb0306e0
ToppCell	facs-Lung-nan-3m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CXCR5 MALT1 PTPRC PGAP1 GPR171 KLHL14 TLR1	1.21e-05	171	199	7	43d8fd9b9546e84a652564fe96b514b34b06262b
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MIS18BP1 TRIM59 ANLN ASPM NCAPD3 KIF20A SMC1B	1.26e-05	172	199	7	c06ca5d075937747952ed915c9db39a9f62072f9
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MNS1 TRIM59 PTPRC ASPM DNAAF4 MKRN2OS KIF20A	1.26e-05	172	199	7	282017db72d0537ac82aecc69393ccde9590be60
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-ependymal_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MNS1 CCDC30 CLHC1 LRGUK CAPS2 BBOX1 DNAAF4	1.31e-05	173	199	7	a7cc63bb3ab41feb9e4072700d44dbbbc62c47c6
ToppCell	Mild/Remission-B_naive-8\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	RAPGEF5 TLE5 TTC28 BAZ2B DGKD PARP14 TLE1	1.31e-05	173	199	7	694d02c4d2dc2de4b344544f9124fec40fcf7d8f
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-Ependyma\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MNS1 CCDC30 CLHC1 LRGUK CAPS2 BBOX1 DNAAF4	1.31e-05	173	199	7	e3e3a67a5a93ef4475224a256d45ae24526383cc
ToppCell	PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MIS18BP1 TRIM59 NF1 ANLN ASPM KIF20A METTL13	1.35e-05	174	199	7	c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BNC1 ANLN PGAP1 GPR171 CCDC14 MYO1H AGR3	1.35e-05	174	199	7	e70cc623a3a6aceec813ed852fec0c4240561133
ToppCell	PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MIS18BP1 TRIM59 NF1 ANLN ASPM KIF20A METTL13	1.35e-05	174	199	7	72df66319f6efbd88ecf439013d97409fbf3cb52
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BNC1 ANLN PGAP1 GPR171 CCDC14 MYO1H AGR3	1.35e-05	174	199	7	9bb8159a62640756d18ecbade3bf32bcbb7dd590
ToppCell	facs-Trachea-24m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MNS1 LRGUK DNAH5 BBOX1 MAP3K19 AGR3 DNAAF1	1.35e-05	174	199	7	f1510b0f7771936adf29ae3572feab55db31832b
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BNC1 ANLN PGAP1 GPR171 CCDC14 MYO1H AGR3	1.35e-05	174	199	7	b6725086fe5a2b057c7c495ec63c970ac52c2580
ToppCell	facs-Trachea-24m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MNS1 LRGUK DNAH5 BBOX1 MAP3K19 AGR3 DNAAF1	1.35e-05	174	199	7	5d5d2fc60afff47f997751e8e9ca1367a22d19ec
ToppCell	10x_5'_v1-Neoplastic-Stem-like-OPC-like\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MNS1 RAPGEF5 FAM111B ANLN ASPM TTC28 KIF20A	1.41e-05	175	199	7	cc596907ea1a64ab7b5a8c7d4ad12e6ee59bfed9
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MIS18BP1 TRIM59 ANLN ASPM NCAPD3 KIF20A SMC1B	1.41e-05	175	199	7	a154b28b0b2180652d51d4c7d804b3b81b35899e
ToppCell	PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MIS18BP1 TRIM59 PTPRC ASPM GPR171 GTF2A1L KIF20A	1.41e-05	175	199	7	ae7e0448ffd11b8908d0f6d99ff737faf5eca4bf
ToppCell	10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MNS1 RAPGEF5 FAM111B ANLN ASPM TTC28 KIF20A	1.41e-05	175	199	7	8a3abf40146ae3459d97cdf865c1c8f6b92ac639
ToppCell	10x_5'_v1-Neoplastic-Stem-like\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MNS1 RAPGEF5 FAM111B ANLN ASPM TTC28 KIF20A	1.41e-05	175	199	7	a8400e7e47379901dcab5f2e364c3ff17765b4b9
ToppCell	10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MNS1 RAPGEF5 FAM111B ANLN ASPM TTC28 KIF20A	1.41e-05	175	199	7	378d2b79edac91fc74eee0fb42bb29dd9b07c36f
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Endothelial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAPGEF5 PLCB4 ABCG2 PLXNA2 PARP14 PREX2 CTNNA1	1.51e-05	177	199	7	ca5a30b3e7bcfdd8de01ceaf7449735b5cd503af
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Endothelial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAPGEF5 PLCB4 ABCG2 PLXNA2 PARP14 PREX2 CTNNA1	1.51e-05	177	199	7	f471f7747d6e8db7546899019af9508f48a14f89
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Endothelial-endothelial_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAPGEF5 PLCB4 ABCG2 PLXNA2 PARP14 PREX2 CTNNA1	1.51e-05	177	199	7	cd0684b876c2a7d5fe7e2773e8e25bb61ecbc795
Drug	Chloroprene	HDAC9 AGO2 CCDC30 RAPGEF5 ASH1L SRPK2 PFKFB1 CXCR5 BNC1 BMP5 LRGUK PTPRC PLCB4 GPR171 ABCG2 PLXNA2 FAT4 BAZ2B FPR2 RAPGEF4 AGR3 TEX11 CCDC141 PREX2 ZFHX4 TLE1 TLR1 RASD1 PHF14 LRRC8B DNAAF1 PRODH	1.69e-07	1348	196	32	ctd:D002737
Disease	Moyamoya disease	HDAC9 DOCK9 WNT9A RAPGEF4 LRP1	5.75e-06	40	190	5	MONDO_0016820
Disease	ataxia telangiectasia (implicated_via_orthology)	ATR ATM	4.12e-05	2	190	2	DOID:12704 (implicated_via_orthology)
Disease	Primary ciliary dyskinesia	DNAH5 DNAAF4 DNAH1 DNAAF1	8.35e-05	36	190	4	cv:C0008780
Disease	Primary Ciliary Dyskinesia	DNAH5 DNAAF4 DNAH1 DNAAF1	2.39e-04	47	190	4	C4551720
Disease	Myopathy, Centronuclear, Autosomal Recessive	SPEG BIN1	2.45e-04	4	190	2	C0410204
Disease	stroke	HDAC9 LRCH1 SEMA3A STON1 ZFHX3 NIN	3.52e-04	144	190	6	EFO_0000712
Disease	juvenile myelomonocytic leukemia (implicated_via_orthology)	NF1 FLT3	4.07e-04	5	190	2	DOID:0050458 (implicated_via_orthology)
Disease	p-tau measurement, cerebrospinal fluid biomarker measurement	ADGRL2 TTC28	4.07e-04	5	190	2	EFO_0004763, EFO_0006794
Disease	amino acid measurement	UTP6 SETX ABCG2 ADGRL2 HNRNPLL PLXNA2 FAT4 GTF2A1L FASTKD2 LRRK1 RERGL LRCH4 PRODH	4.82e-04	678	190	13	EFO_0005134
Disease	status epilepticus (biomarker_via_orthology)	CFL1 ABCG2 ANK3 GRIA2 ATM	4.82e-04	100	190	5	DOID:1824 (biomarker_via_orthology)
Disease	early-onset Parkinson's disease (implicated_via_orthology)	SYNJ1 SYNJ2	6.08e-04	6	190	2	DOID:0060894 (implicated_via_orthology)
Disease	breast carcinoma (is_marker_for)	ABCG2 IGF2R ZFHX3 ATM	8.79e-04	66	190	4	DOID:3459 (is_marker_for)
Disease	sick sinus syndrome	CCDC141 ZFHX3	1.13e-03	8	190	2	MONDO_0001823
Disease	familial sick sinus syndrome	CCDC141 ZFHX3	1.13e-03	8	190	2	MONDO_0012061
Disease	DNA methylation	HDAC9 GALR1 CCDC30 CFL1 SUCLG1 SEMA3A AP1G1 ADGRL2 FAT4 AGR3 ANKRD50 TLR1	1.18e-03	656	190	12	GO_0006306
Disease	childhood onset asthma	CCNI2 CXCR5 PTPRC SYNJ2 TLR1 LRP1 PHF14 THAP12	1.52e-03	334	190	8	MONDO_0005405
Disease	Adenoma, Microcystic	NF1 ABCG2 PRL	1.60e-03	36	190	3	C0205648
Disease	Adenoma, Monomorphic	NF1 ABCG2 PRL	1.60e-03	36	190	3	C0205649
Disease	Adenoma, Basal Cell	NF1 ABCG2 PRL	1.60e-03	36	190	3	C0205646
Disease	Follicular adenoma	NF1 ABCG2 PRL	1.60e-03	36	190	3	C0205647
Disease	Papillary adenoma	NF1 ABCG2 PRL	1.60e-03	36	190	3	C0205650
Disease	Adenoma, Trabecular	NF1 ABCG2 PRL	1.60e-03	36	190	3	C0205651
Disease	Adenoma	NF1 ABCG2 PRL	1.60e-03	36	190	3	C0001430
Disease	age of onset of asthma	HDAC9 PTPRC TTC28 TLR1	1.72e-03	79	190	4	OBA_2001001
Disease	triacylglycerol 54:1 measurement	IGF2R ZFHX4	1.79e-03	10	190	2	EFO_0010419
Disease	3-methyl-2-oxobutyrate measurement	FAT4 ANKRD50	1.79e-03	10	190	2	EFO_0021020
Disease	urate measurement	MYO9A RAPGEF5 CFL1 DHX38 ASH1L TMEM11 BMP5 SUMO1 ABCG2 ADGRL2 BAZ1B DNAH1 POLR3C LRP1	2.07e-03	895	190	14	EFO_0004531
Disease	triacylglycerol 56:2 measurement	SLC5A12 ZFHX4	2.18e-03	11	190	2	EFO_0010429
Disease	descending aortic diameter	HDAC9 GALR1 CCDC141 LRP1	2.55e-03	88	190	4	EFO_0021788
Disease	obesity (implicated_via_orthology)	BMP5 FLII FAT4 ZFHX4 ZFHX3 PRKCI	2.78e-03	215	190	6	DOID:9970 (implicated_via_orthology)
Disease	fibromuscular dysplasia	STON1 RERGL LRP1	2.87e-03	44	190	3	EFO_1000938
Disease	grey matter volume measurement	NTN1 ADGRL2 STON1	2.87e-03	44	190	3	EFO_0005420
Disease	late-onset Alzheimers disease	HDAC9 RAPGEF5 SEMA3A ADGRL2 BIN1 ANK3 ATM	2.95e-03	292	190	7	EFO_1001870
Disease	Gastric Adenocarcinoma	EPHB4 SPEG ATM	3.06e-03	45	190	3	C0278701
Disease	brain measurement, neuroimaging measurement	HDAC9 OMA1 LRCH1 SEMA3A NTN1 ABCG2 ANK3 LRCH4 ZFHX3 MRPL32	3.14e-03	550	190	10	EFO_0004346, EFO_0004464
Disease	beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement	FAT4 ANKRD50	3.57e-03	14	190	2	EFO_0004670, EFO_0006794
Disease	acute myeloid leukemia (is_marker_for)	NF1 ABCG2 FLT3	3.89e-03	49	190	3	DOID:9119 (is_marker_for)
Disease	Down syndrome (implicated_via_orthology)	SYNJ1 SYNJ2	4.10e-03	15	190	2	DOID:14250 (implicated_via_orthology)
Disease	Autosomal Recessive Centronuclear Myopathy	SPEG BIN1	4.10e-03	15	190	2	C3645536
Disease	diastolic blood pressure, systolic blood pressure	HDAC9 CCDC30 MYO9A SPEG PSMD1 LRCH1 ADK BMP5 ANK3 LRP1 ZFHX3	4.28e-03	670	190	11	EFO_0006335, EFO_0006336
Disease	Inherited oocyte maturation defect	ZP2 PADI6	4.66e-03	16	190	2	cv:CN238505
Disease	primary autosomal recessive microcephaly (is_implicated_in)	ASPM NCAPD3	4.66e-03	16	190	2	DOID:0070296 (is_implicated_in)
Disease	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	PTPRC ABCG2 FLT3	4.86e-03	53	190	3	C1961099
Disease	Acute Cerebrovascular Accidents	HDAC9 LRCH1 ZFHX3	5.12e-03	54	190	3	C0751956
Disease	Ischemic stroke	HDAC9 LRCH1 R3HCC1L PLCB4 STON1 RERGL ZFHX3	5.19e-03	324	190	7	HP_0002140
Disease	Benign neoplasm of stomach	ATR ATM	5.26e-03	17	190	2	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	ATR ATM	5.26e-03	17	190	2	C0496905
Disease	cyclic adenosine monophosphate measurement	ABCG2 RERGL	5.26e-03	17	190	2	EFO_0010473
Disease	Carcinoma in situ of stomach	ATR ATM	5.26e-03	17	190	2	C0154060
Disease	brain volume measurement	HDAC9 SEMA3A BMP5 ABCG2 PLXNA2 STON1 EXOC5 ZFHX4 TLE1 ZFHX3	5.42e-03	595	190	10	EFO_0006930
Disease	Liver carcinoma	ACOX1 FAM111B ACSL4 ANLN ASPM DIRAS3 KIF20A IGF2R ATM	5.80e-03	507	190	9	C2239176
Disease	lipoprotein A measurement	SYNJ2 BAZ1B IGF2R SYTL3	6.03e-03	112	190	4	EFO_0006925
Disease	FEV change measurement, response to bronchodilator	ADGRL2 NWD1 UBR3	6.25e-03	58	190	3	EFO_0005921, GO_0097366

Protein segments in the cluster

Peptide	Gene	Start	Entry
CVKHIIYVDNKAINK	ACSL4	221	O60488
ACGKVVRNELLEKHY	ERICH6	416	Q7L0X2
KQCALAALKDVHNYL	PFKFB1	106	P16118
LTKKYEHVLKCRLSN	EP400	1316	Q96L91
SHLALYQVFKAVKLC	DCANP1	151	Q8TF63
CNYDKILATKKNLDH	ASH1L	1811	Q9NR48
KKLTGIKHELQANCY	CFL1	126	P23528
IIEHIKKKCCYAAFL	ACTL7B	251	Q9Y614
LIANLAAANCYKKEK	ADK	151	P55263
LCKTVIALHKVNFYC	CXCR5	121	P32302
NIRKCYCAKKHSQVI	CAPS2	541	Q9BXY5
LSCVKELKDHSALKY	ARMH2	186	H3BNL8
KNKHVSLCIFTARIY	APOBEC3G	301	Q9HC16
QKCEEILHKIVKYRF	BAZ1B	1346	Q9UIG0
HLDYITQACLKNKDV	BAZ2B	1751	Q9UIF8
HHLEDCQYSQALKKV	AGR3	66	Q8TD06
NHKAHLEKLLQYCET	ALDH1L2	771	Q3SY69
ICEKAFLYEKSFLKH	GZF1	321	Q9H116
LTLAKALDYELCQKH	FAT4	3146	Q6V0I7
VLSFHNICYRVKLKS	ABCG2	36	Q9UNQ0
YNAVHLKIKHKCTIE	BNC1	376	Q01954
LLISVKVKEKYLHCA	CCNI2	181	Q6ZMN8
KVKEKYLHCATITSL	CCNI2	186	Q6ZMN8
FIFHCALQKKVRKEY	ADGRL2	1081	O95490
RNIEYIAKCLKDHKA	CHRNA9	426	Q9UGM1
LDVKHCTQKYLCNAA	ANKRD50	416	Q9ULJ7
IHKETDLLKCIQTYL	CCDC14	341	Q49A88
YINELCTVLKAHSAK	DAXX	126	Q9UER7
CAKHKLYQFLHLRKA	ASPM	2446	Q8IZT6
CTVAQYFKDRHKLVL	AGO2	306	Q9UKV8
VNPKNKTHACYLKEL	NWD1	251	Q149M9
HLCLYNLSVIHKKKY	MTF2	271	Q9Y483
CKKDYAVQIHILKAD	NTN1	491	O95631
HTEDLLRVFCSYQKK	R3HCC1L	656	Q7Z5L2
VQYCDVLHKKALRNK	RASD1	211	Q9Y272
TKLCNDHEVLTFIKY	HNRNPLL	471	Q8WVV9
VLTAAHCLKEGLKVY	KLK13	71	Q9UKR3
VCLKGKLHIFKYLST	LRCH4	246	O75427
LHCLKNKYFKELEDL	NSUN2	91	Q08J23
SYLRKKAALCAVHVI	AP1G1	151	O43747
YVEKCIHLNRDILKT	PADI6	561	Q6TGC4
RQGYKCINCKLLVHK	PRKCI	166	P41743
CIKGKVHIFKYLNIQ	LRCH3	261	Q96II8
EIKLSLKACQVYIQH	FLII	1216	Q13045
NRVEKKKLQHTYLCE	MIS18BP1	151	Q6P0N0
SYLRNKKEICIAKHN	JMY	621	Q8N9B5
ALLSLHLFYKKCAQL	EPHB4	186	P54760
KDYVHCLHKVLFTEQ	INTS1	606	Q8N201
QKLKEHLVFTVCLSY	MALT1	676	Q9UDY8
CAKKAHKLQSENLYR	NRAP	1156	Q86VF7
ASGLAYLHKKNIIFC	LRRK1	1371	Q38SD2
YLHKKNIIFCDLKSD	LRRK1	1376	Q38SD2
VLEEKLKYAIHFCKS	HERC2	4776	O95714
ELDLFTYLKHCAKNI	DST	2966	Q03001
TYLKHCAKNIKAKDV	DST	2971	Q03001
IVAICYGLIAAKIHK	FPR2	216	P25090
LHKDNTTCYEFKKFL	LRP1	1571	Q07954
HIYLKIKCQVNSSVE	ANLN	971	Q9NQW6
AYAKHECNLIFRLKD	DDX55	431	Q8NHQ9
IISKHEICIIKYGNK	FSIP2	4836	Q5CZC0
AEIAKHCGFKYKLTI	GRIA2	451	P42262
DLKVHLYKCAAQRES	PLXNA2	796	O75051
RKDIFQDIVKYHVKC	PDE6A	446	P16499
KLKIFHCQVTACLIY	GPR171	81	O14626
ILKARKAYEHALQDC	NRDE2	871	Q9H7Z3
EYKDILRKAVQKICH	PHRF1	1591	Q9P1Y6
YCDLHVIKRDALQKV	KCNH1	666	O95259
CTKGKVHIFKYLSIQ	LRCH1	276	Q9Y2L9
CGYVHLQKLDLSANK	LRGUK	146	Q96M69
QEKLHVEYNKLCESL	PHF14	651	O94880
VFHLKNLKELYLSGC	LRRC8B	506	Q6P9F7
KTPDQLNKHYRLCAK	THAP12	46	O43422
CLYFKIHNALKAAKE	FAM24B	21	Q8N5W8
QFKKDGHCLKEIYLV	PARP14	946	Q460N5
KLQCHITYLEKNLDE	CCDC105	421	Q8IYK2
VVLTLLICHKYKKQF	FLT3	556	P36888
ICFCYAKVLNHLHKK	GALR1	216	P47211
SKKCIEYLAELTRHN	DNAH1	2786	Q9P2D7
VKSKIASKYHDLECQ	EXOC5	181	O00471
HAIVLAQLITKGKCY	ACOX1	186	Q15067
CHYVVVKLFSEKLLK	ACOX1	531	Q15067
AYISNCHKTKLKSIL	ATM	1391	Q13315
LLKAALCHLLQYFLK	ATR	341	Q13535
YKQVCKIAALHGLEE	KLHL14	186	Q9P2G3
LYKCLQGKDETAVLH	CCDC107	81	Q8WV48
CSAHKEYALKKQQLT	CCDC141	446	Q6ZP82
YLCFLQKHQSETALK	DOCK9	1436	Q9BZ29
YCHQLNICSKVKAEV	CTNNA1	786	P35221
KKLYTLDGKQVTCLH	DCX	226	O43602
YCDFSVQSKHKIIEL	BBOX1	266	O75936
EDKQLAICLKYAGVH	C1GALT1C1L	216	P0DN25
SLTAEYKHCQQKIKE	CCDC30	306	Q5VVM6
KSQLKEVCKHSIEYF	ANK3	3986	Q12955
FTHKKICKNLKDIYE	ANKMY2	351	Q8IV38
QACKKHELYVSFRDL	BMP5	351	P22003
SSLQKLCKQHKLYIT	DNAAF1	91	Q8NEP3
LYLNRAACHLKLKNL	DNAAF4	326	Q8WXU2
HRTYKNLEQKVLLEC	DGKD	811	Q16760
HVCAVTKALAQYPLK	EME2	246	A4GXA9
VKLVLKHNRYFVESC	ERCC3	166	P19447
YKVTAKCFGHLTKQL	HDAC9	926	Q9UKV0
YLCISLAQAHILKKA	METTL13	156	Q8N6R0
INELHEKGSKLCIYA	FAM111B	201	Q6SJ93
ILTAAHCLYQAKRFK	F10	271	P00742
YSCKNLIDLQKHLDT	HINFP	291	Q9BQA5
HEASKKLNECLQEVY	BIN1	76	O00499
YELICKIKGNNLHKF	DIRAS3	131	O95661
CPALIYKKIHKNALS	SLC38A10	361	Q9HBR0
KALKHVNIVAYLGTC	MAP3K19	1116	Q56UN5
KLEKTKGCHLYAINT	GARNL3	581	Q5VVW2
TLYKLCEEQLSKQVH	DNAH5	2136	Q8TE73
LYHNCIKTIPEAIKN	LRCH2	141	Q5VUJ6
IVIKNLHDDSCYCKV	OSBPL3	706	Q9H4L5
KLGIKCFYHNADLVS	NOXRED1	121	Q6NXP6
LLQVQDCHVLKYTSK	MRPL3	121	P09001
DSHKIDNYLKLLKCR	PRL	206	P01236
KLVDENYCKKLHVQA	MNS1	16	Q8NEH6
KLECKFVQKHKTYDL	IGF2R	1991	P11717
HSLEICIKACKNLAY	SYTL3	321	Q4VX76
AHELKLLSECQYKQL	UTP6	361	Q9NYH9
KFIKIAAHCKEYKNL	RAPGEF4	846	Q8WZA2
TVYEDQLAKHLKKCN	TRMT13	66	Q9NUP7
LKQKHVLCAYCYEKV	MRPL32	116	Q9BYC8
LHCTQVDKIVAQYDK	PLCB4	956	Q15147
NFESIYKKHLCLERK	RERGL	36	Q9H628
YKKHLCLERKQLNLE	RERGL	41	Q9H628
TIYAAHKQAKACLIS	SYNJ1	191	O43426
IRTVYASHKQAKACL	SYNJ2	191	O15056
IYCAEDLHLKKHQSV	FER1L5	331	A0AVI2
HLNRKKLVSICEQYG	NIN	201	Q8N4C6
KLIKQLGEHKRVYQC	PRDM15	726	P57071
NAYKLHTLDTCLKLD	FASTKD2	536	Q9NYY8
HKIAQVKLCKAYQEA	PNMA3	246	Q9UL41
RCLDYVLEELKHNAK	PRODH	476	O43272
CLDDHKYKQAIGIAL	PSMD1	141	Q99460
DDLCQALLRHYSAKK	RAPGEF5	116	Q92565
CDKNYRHDAVKILKL	SETX	2451	Q7Z333
FVHECIKTILKLYKG	PGAP1	146	Q75T13
TTHLKKLKESYCQRQ	SUMO1	41	P63165
LKECANFIKVLKAYN	SEMA3A	111	Q14563
VLAFCYRKAKKIHSN	SPANXN1	51	Q5VSR9
IALADKHATLSVCYK	MTA1	56	Q13330
KDARYLAVKEVLCHL	OMA1	256	Q96E52
SRQHLYVDKNTKIIC	SUCLG1	46	P53597
EYLDLSHNKLVKISC	TLR1	96	Q15399
QKKHLVEILSYHNCD	TASOR	1396	Q9UK61
LSKVRQSLKNVYHKC	CCDC54	21	Q8NEL0
ALAQIVYSECGLHKK	CLHC1	421	Q8NHS4
LLQHICAKVVDKSEY	NCAPD3	356	P42695
LQAQYHSLKLECDKL	TLE5	36	Q08117
CPKHIAKYLQAEAVK	SENP3	491	Q9H4L4
CSKQYDKACRLKIHL	ZXDB	431	P98169
LQAQYHSLKLECEKL	TLE1	36	Q04724
KYQLHLHESCVLSLK	TLE1	691	Q04724
CDYTTKVKLNLVQHV	ZFHX4	1026	Q86UP3
AHLVIHTGEKLYKCN	ZNF880	341	Q6PDB4
DSKIFQCDKYVKVFH	ZNF92	141	Q03936
LVITALKCHKYDRNI	ZER1	396	Q7Z7L7
LFVKHCKVEVYLLEL	USP4	126	Q13107
KHKLTLESLYQAVCD	USP4	611	Q13107
HNTIALAALVYCVKK	TMEM11	171	P17152
KKALCVLVQHNLVSY	POLR3C	51	Q9BUI4
AGKALIKFNHCEKYI	MKRN2OS	6	H3BPM6
LNKCSLNYICEKLEH	STON1	221	Q9Y6Q2
VIANKLGKAACYAHL	SPEG	1261	Q15772
HQDKQLLLSYLEKCL	STAG3	1021	Q9UJ98
EHVSISIDQIYKKLC	SMC1B	1071	Q8NDV3
VIVCQYDKIHRSKNK	GTF2A1L	436	Q9UNN4
LDLRKKAACIAEQYH	KIF20A	801	O95235
KAACIAEQYHTVLKL	KIF20A	806	O95235
VLVLCYRKTKKIHSN	SPANXN5	51	Q5MJ07
CGKIFIHKSNLIKYQ	ZNF75CP	381	Q92670
QVLQGLDYLHSKCKI	SRPK2	196	P78362
LNKLLKYEDCKVHQR	TRPV6	101	Q9H1D0
TEHNKECLINISKYK	NF1	36	P21359
EEQKIRLHYVACKLL	TEX11	91	Q8IYF3
ICVLNELHEALKKYH	USP50	141	Q70EL3
KCICAAYFHQAAKLK	DHX38	1071	Q92620
EYCSNHEKAQKLLLE	PREX2	121	Q70Z35
CKGLNIVHRIKAYKS	TEX30	66	Q5JUR7
AKKLLYCSLCKVAVN	ZNF385B	281	Q569K4
GKKAIDCLRQALHYA	TTC17	1031	Q96AE7
DVKCLLLLAKVYKSH	TTC21A	836	Q8NDW8
KLLRKCENKHIANYI	SF3B3	976	Q15393
KECGKTFKLHSYLIQ	ZNF404	386	Q494X3
IHLLCVGAYKILQKS	TMEM241	156	Q24JQ0
CLQVHQKIHTEEKLY	ZNF112	401	Q9UJU3
DLHDKLSQAKAYCNL	TTC28	666	Q96AY4
NACVKKSHEKYLIAL	UBR3	286	Q6ZT12
AAQAHYKACDRLKLE	WNT9A	51	O14904
NYIEDCIAQKHSLIK	VPS33A	391	Q96AX1
IYRLSQNKTCKKHIS	ZMYM1	791	Q5SVZ6
VLLSAFHICKFLQAK	ZSWIM1	166	Q9BR11
CKTEKHAKLALYFNL	SLC5A12	266	Q1EHB4
YHCELKNLREKEKQL	SMC5	211	Q8IY18
THLSKNYKAVCLELK	TEX35	11	Q5T0J7
QAQYHSLKLECEKLA	TLE2	36	Q04725
RHNVICQLLSDYKEK	POTEH	386	Q6S545
IYDLHKKRSCNLDEQ	PTPRC	601	P08575
LKTKLSEKCLLHQFY	ZP2	321	Q05996
SEKCLLHQFYLASLK	ZP2	326	Q05996
KVKNILCHIFYLLKE	TRIM59	381	Q8IWR1
HAVYCRDVLKLKKGQ	UGGT1	876	Q9NYU2
ALCKKYAELLEEHRN	TXLNA	191	P40222
VLHKTEDYLRQVLCK	ATP6V0A2	276	Q9Y487
LHCKTDKHVQKYQLV	ZFHX3	1001	Q15911
CDLNNLHLKKDYQSV	ZNF736	106	B4DX44
KNNDLLYRHLKEVLC	MYO1H	531	Q8N1T3
LYRHLKEVLCKSKNI	MYO1H	536	Q8N1T3
NKLHLDKTKCYVLAE	MYO9A	51	B2RTY4